Pain Over Two Years After Start of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: Results From a Swedish Randomized Controlled Trial-Reference-Cited by-同舟云学术

Pain Over Two Years After Start of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: Results From a Swedish Randomized Controlled Trial

Published:2021-08-02 Issue:9 Volume:73 Page:1312-1321
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Olofsson Tor¹^ORCID,Wallman Johan K.¹^ORCID,Jöud Anna²,Schelin Maria E. C.²,Ernestam Sofia³,Vollenhoven Ronald⁴,Saevarsdottir Saedis⁵,Lampa Jon⁴

Affiliation:

1. Lund University Skåne University Hospital Lund Sweden

2. Lund University Lund Sweden

3. Academic Specialist Centre Stockholm Health Services and Karolinska Institutet Stockholm Sweden

4. Karolinska Institutet Stockholm Sweden

5. Karolinska Institutet, Stockholm, Sweden, and University of Iceland and deCODE genetics Reykjavik Iceland

Funder

Lunds Universitet

Vetenskapsrådet

Greta och Johan Kocks stiftelser

Reumatikerförbundet

Stockholms Läns Landsting

Schering-Plough

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24264

Reference29 articles.

1. Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort

2. Patient‐Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics‐Treated Patients With Rheumatoid Arthritis

3. Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment

4. Patient Perceptions concerning Pain Management in the Treatment of Rheumatoid Arthritis

5. The role of proinflammatory cytokines in the generation and maintenance of joint pain

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapy: results from the ICEBIO registry;Scandinavian Journal of Rheumatology;2024-06-04

2. Sinomenine ameliorates fibroblast-like synoviocytes dysfunction by promoting phosphorylation and nuclear translocation of CRMP2;Journal of Ethnopharmacology;2024-04

3. Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?;Scandinavian Journal of Rheumatology;2023-11-30

4. Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3);Annals of the Rheumatic Diseases;2023-09-11

5. Joint tenderness at 3 months follow-up better predicts long-term pain than baseline characteristics in early rheumatoid arthritis patients;Rheumatology;2023-06-14